Bone Marrow and Peripheral Blood Immune Responses Study
Influenza
About this trial
This is an interventional basic science trial for Influenza focused on measuring Influenza Vaccine, Bone Marrow, Immune Response
Eligibility Criteria
Inclusion Criteria: All genders, races and ethnic groups (inclusive of women and minorities) are eligible for this trial, as influenza and the associated range of clinical issues accompanying influenza infection can impact people of all genders, races and ethnic groups. It is anticipated that the distribution of study participants will be diverse with regard to these demographics. Adults able to provide consent on their own Healthy adults Exclusion Criteria: Adults unable to consent Women who are pregnant or nursing a child may not take part in this study. If a woman of childbearing potential is enrolled in this study, she and the study doctor must agree on a method of birth control to use throughout the study. Enrollees who think that they may have gotten pregnant during the study must tell the study doctor immediately. Pregnant women will be taken out of the study. Prisoners Cognitively impaired or individuals with impaired decision-making capacity Individuals who are vulnerable to coercion or undue influence (human fetuses, or neonates of uncertain viability or non-viable neonates, minors/children, and cognitively impaired adults) will not be eligible for participation in this study.
Sites / Locations
- Emory University HospitalRecruiting
Arms of the Study
Arm 1
Experimental
Influenza Vaccine
Healthy male and female individuals aged 18-64 years will be eligible to participate in this study. Subjects will be offered the opportunity to participate in the study for up to 3 consecutive years, provided eligibility criteria are met each year. Subjects will be re-screened to verify continued eligibility and re-consented prior to subsequent participation and will receive new subject identifiers